|
Financials
|
||
|
BDSRA Board of Directors (As of July 12, 2007)
|
||||||||||||||||||||||||||
|
In order to effectively combat the devastation of the disease and to fully support research efforts to unravel the mysteries on Batten, the worlds of medical science and the victims and their families must meet and work closely together to reach understanding and common goals. In an effort to bring those common goals to fruition, the Batten Disease Support and Research Association - (BDSRA) was formed in July, 1986, by Gary and Judith Grant of Spanaway, Washington, who are parents of three Batten victims. Seeing the tremendous need for a unified entity that would work toward important goals and recognizing, as well, the need for support among victims and their families, the founders designed the association to:
First described in 1826 -
more than 170 years ago - Batten Disease
(Neuronal Ceroid Lipofuscinoses), thought to be one of the most
common neurodegenerative diseases, remains an unsolved mystery today...a
puzzling disease that assures its victims of only one consistent manifestation...early
death. An inherited, degenerative
neurological disease, - Batten may
affect persons of any age, but primarily affects infants, toddlers and
school age children, beginning unexpectedly and leading to a progressive
loss of brain function that later destroys bodily functions, eventually
leaving the victim totally helpless. Whether in the case of infantile
(Santavnori), late infantile (Jansky, Bielschowsky), juvenile (Batten,
Spielmeyer, Sjogren), or adult type (Kuf, Parry), the early symptoms of
Batten Disease are confusing ones.
It strikes without warning, affecting vision and causing seizures or convulsions.
Possibly most frustrating of all is the fact that Batten Disease is rarely diagnosed immediately, often being mistaken for epilepsy or mental retardation, even schizophrenia. And once diagnosed, there is no satisfactory treatment and no cure. The clinical course of the disease includes a marked decline in cognitive function; personality and behavior changes; loss of communication and motor skills; poor circulation; decrease in muscle mass; hyperventilation; hallucinations, and, finally, deterioration to a vegetative state that ends in death. |
||||||||||||||||||||||||||
|
Last Updated/Reviewed
12/28/07
|
||||||||||||||||||||||||||